Tag: Daiichi Sankyo
Billion dollar deal for Munich biotech start-up Tubulis
Tubulis logo The young biotech company could earn over a billion dollars with the partnership. (Photo: tubules) Frankfurt The Munich-based biotech company Tubulis has agreed a potentially multi-billion dollar deal…
Biontech decides billion dollar deal for new cancer drugs
Biontech Just two weeks after the multi-million dollar deal with the US cancer specialist OncoC4, the Mainz-based company agreed on another partnership. (Photo: dpa) Frankfurt Biontech is stepping on the…
Pfizer acquires cancer specialist Seagen for $43 billion
Pfizer logo The US pharmaceutical company takes over the cancer specialist Seagen for 43 billion dollars. (Photo: AP) Frankfurt The US group Pfizer is using its billions in revenue from…
Pfizer is probably exploring the Seagen takeover – the pharmaceutical industry is facing a wave of takeovers
In the Pfizer lab Important patents are expiring at the US pharmaceutical company. (Photo: Bloomberg) Frankfurt Another major takeover may be in the offing in the pharmaceutical industry. According to…
After the Corona boom, the pharmaceutical industry is facing a dip in growth
Frankfurt In the past two years, the corona pandemic has given the pharmaceutical industry the strongest sales boost in decades. But the boom is abating and the industry will have…
The new magic bullet against cancer
Monday 13 June 2022 Log in subscription Newsletter podcast Club e-paper archive Shop jobs Inside my news Home politics Germany Economy International Economic Education company Industry energy Trade + consumer…
Record funding for German cancer specialist Emergence Therapeutics
Tumor cells Illustration of breast cancer treatment with an antibody drug. (Photo: picture-alliance / medicalpictur) Frankfurt The Duisburg-based biotech company Emergence Therapeutics has raised a total of 87 million euros…